Achieve life sciences to announce second quarter financial results and host conference call and webcast on august 7, 2025

Seattle and vancouver, british columbia, july 24, 2025 (globe newswire) -- achieve life sciences, inc. (nasdaq: achv), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence for smoking cessation, today announced it will report its second quarter 2025 financial results and provide a corporate update on the cytisinicline development program on thursday, august 7, 2025, at 8:30 am edt. to access the webcast, please use the following link: 2q25 earnings webcast.
ACHV Ratings Summary
ACHV Quant Ranking